$17.00
-1.03-5.71%
Last update: Nov 6, 4:18 AM
Relay Therapeutics Inc
RLAYNASDAQ
The average analyst price target for Relay Therapeutics is $21.95, 26.5% above the current price. Of 16 analysts, 15 rate it Buy and 1 Hold. Targets range from $4 to $31. The latest change came on Aug 20, 2026, when HC Wainwright & Co. raised its price target on Relay Therapeutics from $28 to $29 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
